- Home
- BOLD
as 11-22-2024 4:00pm EST
Stocks
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 60.4M | IPO Year: | 2024 |
| Target Price: | $23.00 | AVG Volume (30 days): | 84.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.21 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.33 - $15.24 | Next Earning Date: | 11-07-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Boundless Bio Inc. Common Stock News
BOLD Breaking Stock News: Dive into BOLD Ticker-Specific Updates for Smart Investing
GlobeNewswire
17 days ago
Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
19 days ago
Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference
GlobeNewswire
a month ago
Boundless Bio Announces Departure of Chief Financial Officer
Simply Wall St.
2 months ago
Is Boundless Bio (NASDAQ:BOLD) In A Good Position To Invest In Growth?
GlobeNewswire
2 months ago
Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference
Insider Monkey
3 months ago
Boundless Bio, Inc. (BOLD): Why Should You Buy This New Penny Stock Now?
GlobeNewswire
3 months ago
Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results
Business Wire
6 months ago
Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Compare BOLD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BOLD Boundless Bio Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.